A new validation study on the prognostic performance of Stratipath Breast.
Stratipath is excited to announce the publication of a new validation study on the prognostic performance of Stratipath Breast—the first AI-based CE-marked medical device for risk stratification of breast cancer using routine H&E histopathology images.
Swelife conducted an interview with our Chief Medical Officer and co-founder Johan Hartman
Swelife conducted an interview with our Chief Medical Officer and co-founder Johan Hartman
Stratipath was honored with the Dream Award at the Techarenan Challenge in Almedalen.
Stratipath was honored with the Dream Award at the Techarenan Challenge in Almedalen.
Seminar – Almedalen. ”AI can predict relapse in breast cancer – How does this affect breast cancer care?”
Seminar – Almedalen. ”AI can predict relapse in breast cancer – How does this affect breast cancer care?”
Seminar – Almedalen ”No precision medicine without pathology”
Seminar – Almedalen ”No precision medicine without pathology”
Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine
Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine
Stratipath is the winner of the Health Tech Award 2024 at Vitalis!
Stratipath is the winner of the Health Tech Award 2024 at Vitalis!
Interview with Stratipath CTO Mattias Rantalainen about SwAIPP
Mattias Rantalainen, co-founder, CTO of Stratipath, and coordinator of SwAIPP (Sweden AI Precision Pathology), is being interviewed by Vinnova regarding innovation in precision medicine. “For us, building evidence around the solutions we develop is important. We collaborate internationally in several ongoing validation studies. We also gain synergies by conducting overlapping activities with a Nordic consortium. […]
MedTechLabs labs interview with Stratipath CEO, Fredrik Wetterhall,
MedTechLabs labs recently interviewed our CEO, Fredrik Wetterhall, discussing the rapid development from research to clinical use and the future trajectory of Stratipath.
Stratipath is proud to be a part of Proscia’s new partner alliance ”Proscia Ready”
Stratipath is proud to be a part of Proscia’s new partner alliance ”Proscia Ready”
